Equine Probiotics

Imagilin Technology's Novel Patent-Pending Probiotic Benefits General Health of Horses and Other Equine

-New product uses a unique strain of probiotics in the equine industry-

Frederick, MD, (Dec. 5, 2010) - Equine health will greatly benefit from Imagilin Technology's new probiotic product MitoHorse™ . The innovative product not only will help horses and ponies, but it greatly differentiates itself from the currently available products in many ways. MitoHorse™  contains a unique formulation of  Pediococcus acidilactici which Imagilin believes to be superior to the commercially available Lactobacillus and Bifidobacterium bacteria strains. Attributes about Pediococcus that defines it from other bacteria strains are a shelf life of 2 years at room temperature, higher resistance to oxygen, higher resistance to the acidic environment of the stomach, and the ability to be used concurrently as an adjunct with antibiotic treatments. MitoHorse™  also includes a blend of Saccharomyces boulardii that has been found in several research papers to be beneficial for equine.

"l believe probiotics have a very promising future in veterinary medicine," said Dr. Bruce Little, former executive vice president of the American Veterinary Medical Association (AVMA), "Hopefully research will begin to validate many of the potential benefits of probiotic products." MitoHorse™  is available for use by veterinarians only. Clients who wish to use MitoHorse™  should consult their veterinarians about the availability of this product for their animals. Learn more at www.imagilin.com.

Contact:

Joshua Lin

Imagilin Technology LLC

(30r) 418-6147

Jhy-Jhu (J.J.) Lin

Imagilin Technology LLC

(301) 418-6147

93 Monocacy Boulevard, Suite A9, Frederick, MD 21701

Phone: 301 -41 8-61 47. Fax: 301 -41 8-61 48